Israel has observed a 49.85 million (23.2%) increase in the research & development by business enterprise, pharmaceutical industry in current ppp $, which now stands at 265.12 million.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Israel
No matching regions
Similar regions to Israel
Business R&D pharmaceutical in current PPP $
Israel Business R&D pharmaceutical in current PPP $ between 2010 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 265.12M | +49.85M |
| 2020 | 215.28M | +14.83M |
| 2019 | 200.45M | +5.48M |
| 2018 | 194.97M | -69.25M |
| 2017 | 264.22M | -78.31M |
| 2016 | 342.53M | -7.62M |
| 2015 | 350.14M | +70.76M |
| 2014 | 279.39M | -104.53M |
| 2013 | 383.92M | +97.67M |
| 2012 | 286.24M | +3.03M |
| 2011 | 283.21M | -29.29M |
| 2010 | 312.50M |